VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
UGUnited-Guardian, Inc.
$7.29$33M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

UG logoUnited-Guardian, Inc.(UG)Earnings, Financials & Key Ratios

UG•NASDAQ
$7.29
15.8× P/E·Price updated Jul 6, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustrySuppliers, Durables and Specialty Retailers
AboutUnited-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.Show more
  • Revenue$11M-13.4%
  • EBITDA$2M-37.2%
  • Net Income$2M-35.2%
  • EPS (Diluted)0.46-35.2%
  • Gross Margin47.73%-10.0%
  • EBITDA Margin22.3%-27.4%
  • Operating Margin21.27%-28.9%
  • Net Margin19.97%-25.2%
  • ROE18.22%-34.8%

UG Price & Volume

United-Guardian, Inc. (UG) stock price & volume — 10-year historical chart

Loading chart...

Volatile Revenue Growth Masks Declining Cash Reserves

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Moderate
Financial:Vulnerable
Cash Flow:Mixed
Primary Risk:Dividend sustainability and liquidity

Key Thesis Takeaways

  • United-Guardian faces a challenging outlook characterized by inconsistent revenue growth and structural margin compression, with gross margins falling from 54% in 2024 to 49.6% in 2026Q1.
  • The company's aggressive dividend policy, exemplified by a $1.1M payout in 2026Q1, appears to be eroding its liquidity position as cash reserves have plummeted from $8.4M in 2024Q2 to $735.9K.
  • Investors should monitor the sustainability of these distributions, as the firm's inability to consistently convert net income into operating cash flow suggests significant operational risk.

Verdict Logic

the company's cash position has declined by over 90% since 2024Q2, and the current dividend yield of 8.4% appears unsustainable given the recent erosion of liquid assets to $735.9K.

UG Growth Metrics

United-Guardian, Inc. (UG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.8%
5 Years-0.82%
3 Years-6.01%
TTM-4.13%

Profit CAGR

10 Years-7.53%
5 Years-8.62%
3 Years-6.42%
TTM-18.11%

EPS CAGR

10 Years-7.47%
5 Years-8.57%
3 Years-6.35%
TTM-17.46%

Return on Capital

10 Years37.23%
5 Years35.19%
3 Years26.1%
Last Year19.24%

UG Recent Earnings

United-Guardian, Inc. (UG) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat Revenue 2/12 qtrs (40%)
Q2 2026Latest
May 8, 2026
Metric
Actual
Est
EPS
$0.18
—
Rev
$3M
—
Q2 2026
Mar 27, 2026
Metric
Actual
Est
EPS
$0.14
—
Rev
$3M
—
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.06
—
Rev
$2M
—
Q3 2025
Aug 8, 2025
Metric
Actual
Est
EPS
$0.14
—
Rev
$3M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 8, 2026
$0.18
$3M
Q2 2026Mar 27, 2026
$0.14
$3M
Q4 2025Nov 6, 2025
$0.06
$2M
Q3 2025Aug 8, 2025
$0.14
$3M
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for United-Guardian, Inc. (UG)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
UG logoUGUnited-Guardian, Inc.Current
$7.29$33.49M15.85-13.43%19.97%18.22%8.26%
IOSP logoIOSPInnospec Inc.
$82.41$2.03B17.65-3.65%6.38%8.64%—
KRMD logoKRMDKORU Medical Systems, Inc.
$4.60$211.29M-80.5622.23%-5.27%-13.61%—
LIQT logoLIQTLiqTech International, Inc.
$0.81$8.06M-0.9113.03%-55.45%-79.65%—
CODA logoCODACoda Octopus Group, Inc.
$9.67$109.08M26.1430.75%17.66%8.33%—
CBT logoCBTCabot Corporation
$87.60$4.57B14.55-7.04%7.97%16.75%—

Compare UG vs Peers

United-Guardian, Inc. (UG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IOSP

Most directly comparable listed peer for UG.

Scale Benchmark

vs ECL

Larger-name benchmark to compare UG against a more recognizable public peer.

Peer Set

Compare Top 5

vs IOSP, KRMD, LIQT, CODA

UG SEC Filings & Documents

United-Guardian, Inc. (UG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 8, 2026·SEC

Material company update

Mar 27, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 27, 2026·SEC

FY 2025

Mar 21, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 12, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 8, 2025·SEC

Get notified when UG posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

UG Frequently Asked Questions

United-Guardian, Inc. (UG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is United-Guardian, Inc.'s revenue?

United-Guardian, Inc. (UG) reported $10.9M in revenue for fiscal year 2025. This represents a 37% increase from $8.0M in 1996.

How fast is United-Guardian, Inc. growing?

United-Guardian, Inc. (UG) saw revenue decline by 13.4% over the past year.

Is UG profitable?

Yes, United-Guardian, Inc. (UG) is profitable, generating $2.4M in net income for fiscal year 2025 (20.0% net margin).

Dividend & Returns
Does UG pay dividends?

Yes, United-Guardian, Inc. (UG) pays a dividend with a yield of 8.26%. This makes it attractive for income-focused investors.

What is UG's return on equity?

United-Guardian, Inc. (UG) has a return on equity (ROE) of 18.2%. This is reasonable for most industries.

What is United-Guardian, Inc.'s free cash flow?

United-Guardian, Inc. (UG) generated $2.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in UG back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →